1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Orthometrix, Inc.

Orthometrix, Inc.

OMRX
Orthometrix, Inc.US flagOther OTC
0.00
USD
- -
- -
4,699.00Market Cap
1996 Y
1997 Y
1998 Y
1999 Y
2000 Y
2001 Y
2002 Y
2003 Y
2004 Y
2005 Y
2006 Y
2007 Y
TTM
Revenue per Share
3.58
2.87
2
0.82
0.5
0.02
0.03
0.05
0.04
0.04
0.05
0.05
0.03
Basic EPS, GAAP
0.31
-2.6
-1.35
-0.1
-0.49
-0.05
0.11
-0.05
-0.06
-0.06
-0.04
-0.02
-0.02
Free Cash Flow per Basic Share
-0.65
-0.45
-0.27
-0.09
-0.01
-0.01
-0.11
-0.04
-0.04
-0.05
-0.03
- -
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
0.62
-2.05
-3.39
-1.23
-1.47
-1.36
-1.29
-1.34
-1.33
-1.04
-1.03
-1.04
-1
Tangible Book Value per Share
2.84
-0.16
0.09
0.16
-0.05
-0.09
0.02
-0.03
-0.03
-0.02
-0.05
-0.06
-0.07
Basic Weighted Avg Shares
7
7
7
22
27
30
30
30
31
42
45
45
48
Sales/Revenue/Turnover
25
21
14
18
13
1
1
2
1
2
2
2
1
Operating Margin (%)
11.8
-103.46
-63.93
-11.24
-12.62
-280.8
-174.36
-82.74
-140.38
-154.29
-69.55
-17.27
-37.87
Depreciation Expense
- -
1
1
1
1
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
2
-19
-10
-2
-13
-2
3
-1
-2
-2
-2
-1
-1
Effective Tax Rate (%)
40.6
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
8.66
-90.52
-67.53
-12.36
-99.08
-239.15
361.57
-85.78
-164.78
-157.68
-83.83
-44.65
-65.85
Working Capital
19
12
2
1
-2
-3
- -
-1
-1
-1
-2
-3
-4
LT Debt
- -
14
5
1
- -
- -
- -
- -
- -
- -
1
- -
- -
Total Equity
27
8
9
11
-1
-3
1
-1
-1
-1
-2
-3
-4
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

•

in mil. unless spec.
Mar'08
Jun'08
Sep'08
ST Debt
2
2
3
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
47
50
50
Market Capitalization
1
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Mar'08
Jun'08
Sep'08
Total Current Assets
1
1
1
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
4
4
4
Payables & Accruals
1
1
1
ST Debt
2
2
3
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-11.77%
-8.27%
25.37%
Free Cash Flow
55.01%
-22.23%
-82.5%
Net Income, GAAP
-14.56%
-27.44%
-45.67%
Sales/Revenue/Turnover
4.17%
27.14%
2%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
1
1
1
- -
2
2007
1
- -
1
1
2
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-0.01
-0.01
-0.01
- -
-0.04
2007
-0.01
-0.01
- -
- -
-0.02
2008
-0.01
-0.01
-0.01
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Reynald G. Bonmati
Full Time Employees
7
Sector
Healthcare
Industry
Medical - Specialties
Address
5621 Strand Boulevard Naples FL United States of America
IPO Date
Aug 2, 1995
Website
orthometrix.com
Similar Companies
Gencurix Inc. (229000.KQ)
Basma Adeem Medical Co. (9626.SR)
Dynamic Medical Technologies Inc. (4138.TWO)
L&C Bio Co., Ltd (290650.KQ)
Shanghai United Imaging Healthcare Co., Ltd. (688271.SS)
General Biologicals Corporation (4117.TWO)
Business
Orthometrix, Inc. engages in the marketing, sale, and servicing of musculoskeletal product lines used in pharmaceutical research, diagnostic, and monitoring of bone and muscle disorders. Its product portfolio includes peripheral quantitative computed tomography (pQCT) bone and muscle measurement systems, whole body vibration systems, ground reaction force plates, and a patented bilateral arm trainer with rhythmic auditory cueing. Orthometrix serves the sports medicine, rehabilitative medicine, physical therapy, fitness, and pain management markets primarily in the United States and Canada. The company operates through two divisions: Healthcare, focused on musculoskeletal research applications, and Sports & Fitness, which markets exercise systems such as Mini VibraFlex and VibraFlex 550. Founded in 1986 and headquartered in White Plains, New York, Orthometrix has in recent years expanded its operations through strategic partnerships, including granting exclusive rights to market its SmartStep® Biofeedback System in South Korea for rehabilitation and physical therapy. The company continues to innovate within the musculoskeletal device segment, emphasizing non-invasive technologies and comprehensive product servicing. Orthometrix maintains a small workforce and operates as a publicly traded company under the ticker OMRX. Orthometrix targets pharmaceutical researchers, healthcare providers, therapists, and fitness professionals, offering advanced diagnostic and therapeutic devices to enhance musculoskeletal mobility and treatment outcomes. Its product offerings support clinical research as well as patient care in rehabilitation and pain management settings. The latest strategic initiatives include expanding product distribution internationally and leveraging technology partnerships to strengthen its market presence and product innovation pipeline. This comprehensive approach positions Orthometrix as a niche player in medical devices, focusing on musculoskeletal health solutions with a dual emphasis on research-grade instrumentation and applied therapeutic equipment. Its product range combined with recent market expansions reflects a focused growth strategy within the healthcare technology sector.